Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells.
about
TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer.Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells.Sanggenon C induces apoptosis of colon cancer cells via inhibition of NO production, iNOS expression and ROS activation of the mitochondrial pathway.Andrographolide enhanced 5-fluorouracil-induced antitumor effect in colorectal cancer via inhibition of c-MET pathway.Clinicopathological analysis of PD-L2 expression in colorectal cancer
P2860
Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells.
@en
type
label
Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells.
@en
prefLabel
Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells.
@en
P2093
P2860
P356
P1433
P1476
Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells.
@en
P2093
Bayasi Guleng
Chuan-Xing Xiao
Guo-Bin Chen
Hui-Qin Xing
Jian-Lin Ren
Li-Fen Wang
Xiao-Ling Wu
Xiao-Xiao Huang
P2860
P304
48027-48037
P356
10.18632/ONCOTARGET.10338
P407
P50
P577
2016-06-30T00:00:00Z